戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 Ao junction can be a frequent source of left atrial tachycardia.
2 as used to simulate the site of origin of an atrial tachycardia.
3  of this study was freedom from recurrent AF/atrial tachycardia.
4 t ablation was performed for recurrent AF or atrial tachycardia.
5  adaptive molecular and cellular response to atrial tachycardia.
6 ), 49% of the patients remained free from AF/atrial tachycardia.
7  to induce paroxysmal atrial fibrillation or atrial tachycardia.
8 rial fibrillation, atrial flutter, and focal atrial tachycardia.
9 reentry, Wolff-Parkinson-White syndrome, and atrial tachycardia.
10 roxysmal atrial fibrillation, and paroxysmal atrial tachycardia.
11 dent right atrial reentry (n=7), and 1 focal atrial tachycardia.
12 nvolving the left atrium compared with right atrial tachycardias.
13  successful in eliminating left versus right atrial tachycardias.
14          These foci usually induce irregular atrial tachycardias.
15 aches for atrial flutters and macroreentrant atrial tachycardias.
16 in 26 (96%) of 27 (95% CI 81% to 100%) right atrial tachycardias.
17 ugh low-voltage regions and aids ablation of atrial tachycardias.
18 nd this drove 30% (7/23) of our postablation atrial tachycardias.
19 sence of LVA (<0.5 mV) and inducible regular atrial tachycardias.
20 lter recordings; and (4) higher incidence of atrial tachycardia (15% versus 41%, P=0.02) and atrial f
21                            Of 27 focal right atrial tachycardias, 18 (67%, 95% confidence interval [C
22 ilure (3%), liver abscesses (3%), paroxysmal atrial tachycardia (3%), thoracic pain (3%), upper gastr
23              Of the 40 patients with annular atrial tachycardia, 4 tachycardias were localized to the
24 s (age 49+/-16 years, 9 females) with either atrial tachycardia (6 patients) or atrial fibrillation t
25 tory of successfully ablated incessant focal atrial tachycardia 64+/-36 months prior, and 20 healthy
26 ed by atrial fibrillation (28.8%), and focal atrial tachycardia (9.5%).
27 attributable to lead failure (14%), sinus or atrial tachycardias (9%), and/or oversensing (4%).
28 imilar to tachycardia cycle length; 2) focal atrial tachycardia: a P-A interval < or =-20 ms; and 3)
29                  Acute procedural success of atrial tachycardia ablation in congenital heart patients
30                        Patients referred for atrial tachycardia ablation underwent dense electroanato
31 chronic tachycardias have been reported with atrial tachycardias, accessory pathway reciprocating tac
32 he AF substrates tested, including sustained atrial tachycardia/AF itself, enhanced post-RFA atrial t
33                                 The 12-month atrial tachycardias/AF-free survival was 62% for patient
34              The outcomes of freedom from AF/atrial tachycardia after 1 or several ablation procedure
35  with AF and 16 patients with atrial flutter/atrial tachycardia) after the initial procedure during a
36                   In a separate data set (12 atrial tachycardia and 10 ventricular tachycardia), we e
37                                      In 1753 atrial tachycardia and 1426 ventricular tachycardia reco
38 nd induce atrial tachyarrhythmias, including atrial tachycardia and atrial fibrillation (AF).
39                               All paroxysmal atrial tachycardia and atrial fibrillation episodes were
40               The RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes) is
41 harges that preceded the onset of paroxysmal atrial tachycardia and atrial fibrillation.
42  A-A-V response was observed in all cases of atrial tachycardia and simulated atrial tachycardia, eve
43 % and 5%, respectively, also had episodes of atrial tachycardia and supraventricular tachyarrhythmia.
44                                      Both in atrial tachycardia and ventricular tachycardia, the vari
45 istry designed to document the prevalence of atrial tachycardia and/or fibrillation (AT/AF) of any du
46  identify the anatomic origin of focal right atrial tachycardias and to define their relation with th
47 prising atrial fibrillation, atrial flutter, atrial tachycardia, and supraventricular tachyarrhythmia
48 ntricular overdrive pacing was diagnostic of atrial tachycardia, and this maneuver could be applied t
49 nd long-term recurrence of AF/atrial flutter/atrial tachycardia are significantly lower using general
50                                Post ablation atrial tachycardias are characterized by low-voltage sig
51 T to adenosine can immediately differentiate atrial tachycardia arising from a focal source from that
52 lly abnormal atrial tissue and mechanisms of atrial tachycardia (AT) after mitral valve (MV) surgery.
53 es recurrence of atrial fibrillation (AF) or atrial tachycardia (AT) after radiofrequency catheter ab
54                        Sixteen patients with atrial tachycardia (AT) after SR-CHD were studied (atria
55 r radiofrequency catheter ablation (RFCA) of atrial tachycardia (AT) arising from the coronary sinus
56 g criteria unequivocally differentiate focal atrial tachycardia (AT) caused by microreentry, triggere
57                                      Regular atrial tachycardia (AT) coexisting with AF occurred in 6
58                                        Three atrial tachycardia (AT) episodes originated from a focus
59                     The device discriminated atrial tachycardia (AT) from atrial fibrillation (AF) on
60 re TAVR: paroxysmal atrial fibrillation (AF)/atrial tachycardia (AT) in 28, advanced atrioventricular
61 eparate focal from atypical macro-re-entrant atrial tachycardia (AT) on the electrocardiogram (ECG).
62 lar fibrillation (VF) preceded by paroxysmal atrial tachycardia (AT) or atrial fibrillation (AF)-in p
63  Here, we assess the efficacy of optogenetic atrial tachycardia (AT) termination in human hearts usin
64 this study was to determine the mechanism of atrial tachycardia (AT) that occurs after ablation of at
65                   Acute conversion to NSR or atrial tachycardia (AT) was achieved in 90% of cases.
66 he feasibility of optogenetic termination of atrial tachycardia (AT), comparing two different illumin
67  adenosine has mechanism-specific effects on atrial tachycardia (AT), such that adenosine terminates
68  atrial fibrillation (AF) or other sustained atrial tachycardia (AT), verified by monthly visits, amb
69 and mechanism of adenosine-insensitive focal atrial tachycardia (AT).
70 with symptomatic atrial fibrillation (AF) or atrial tachycardia (AT).
71 ctrophysiologic (EP) identity of left septal atrial tachycardia (AT).
72 onal reciprocating tachycardia (PJRT; n=12), atrial tachycardia (AT; n=53), and inappropriate sinus t
73  wavefronts, but this is often difficult for atrial tachycardias (AT) after ablation of atrial fibril
74 activation mapping of reentrant scar-related atrial tachycardias (AT) allows efficient radiofrequency
75                                              Atrial tachycardias (AT) during or after ablation of atr
76 onal linear ablation lines in the setting of atrial tachycardias (AT) in patients with persistent AF
77                       The role of subsequent atrial tachycardias (AT) in the context of persistent at
78 ping (ECM), in facilitating the diagnosis of atrial tachycardias (AT).
79                                              Atrial tachycardia/atrial fibrillation accounted for >50
80 y of CRT loss increased, the contribution of atrial tachycardia/atrial fibrillation and SAV/PAV to th
81          Among those with suboptimal pacing, atrial tachycardia/atrial fibrillation was the most comm
82 ostics explained 55.8% of pacing loss: 30.6% atrial tachycardia/atrial fibrillation; 16.6% premature
83 ary outcome was symptomatic recurrence of AF/atrial tachycardia/atrial flutter lasting >30 seconds, d
84                           (3) In 10 cases of atrial tachycardia/atrial flutter, ECM accurately identi
85                                              Atrial tachycardias (ATs) are a significant source of mo
86 jective of this study is to describe complex atrial tachycardias (ATs) that occur after this approach
87 iled noninvasive localization of right-sided atrial tachycardia before radiofrequency catheter ablati
88  change in right atrial pressure, persistent atrial tachycardia caused ARP and ERP to fall by > 10%.
89 flutter is characterized by a macroreentrant atrial tachycardia circuit.
90 urity of the extrastimulus and time to first atrial tachycardia complex were directly correlated (R=0
91          Sustained, self-limited episodes of atrial tachycardia (cycle length, 340+/-56 ms; duration,
92 matic or asymptomatic AF, atrial flutter, or atrial tachycardia), detected by either scheduled or uns
93                                    Sustained atrial tachycardia developed in 22 of 143 patients (15%)
94 ll cases of atrial tachycardia and simulated atrial tachycardia, even in the presence of dual atriove
95                              Most paroxysmal atrial tachycardia events (89%) were preceded by ICNA an
96                                        Focal atrial tachycardia (FAT) is an uncommon cause of suprave
97                                        Focal atrial tachycardia (FAT) is extremely difficult to map a
98 CFAE arm had a higher incidence of organized atrial tachycardia/flutter (24/33 [73%] versus 11/31 [35
99          The ICD should discriminate between atrial tachycardia/flutter (AT), which may be terminated
100 euvers, it can be difficult to differentiate atrial tachycardia from other forms of paroxysmal suprav
101 ecurrence of symptomatic AF, atrial flutter, atrial tachycardia (HR, 0.56 [95% CI, 0.33-0.95]; P = .0
102              A second patient with ALMCA had atrial tachycardia immediately after exercise, with infe
103 al AF in 48 patients (28%) and persistent AF/atrial tachycardia in 123 patients (72%).
104 FAE ablation did not improve freedom from AF/atrial tachycardia in patients with paroxysmal or persis
105 prove the overall rate of freedom from AF or atrial tachycardia in patients with persistent AF (OR, 1
106 itive and specific for the identification of atrial tachycardia in the electrophysiology laboratory.
107 The most common finding was rapid, irregular atrial tachycardias in the region of the pulmonary veins
108                                        Right atrial tachycardias included cavotricuspid isthmus-depen
109                                         Left atrial tachycardias included reentry around the mitral v
110 ce had atrial arrhythmias, including AFL and atrial tachycardia, indicating that Pitx2 haploinsuffici
111  change included atrial premature complexes, atrial tachycardia, interpolated ventricular premature c
112                                              Atrial tachycardia is a frequent acute outcome with coil
113                                              Atrial tachycardia is a well-recognized long-term compli
114                                   Multifocal atrial tachycardia is defined by three distinct P-wavefo
115 ined as an episode of AF, atrial flutter, or atrial tachycardia lasting >30 seconds after a 3-month b
116 acterize the circuit of macroreentrant right atrial tachycardia (MacroAT) in patients after surgical
117 come of infants and children with multifocal atrial tachycardia (MAT).
118     Recent studies have suggested that right atrial tachycardias may also have a characteristic anato
119 romic reciprocating tachycardia (n = 43), 3) atrial tachycardia (n = 19) and 4) atrial tachycardia si
120 ntricular tachycardia (n = 5), and undefined atrial tachycardia (n = 21).
121 n 47 cases: macroreentrant (n = 25) or focal atrial tachycardia (n = 8), atrioventricular nodal reent
122 l fibrillation (n=13), atrial flutter (n=4), atrial tachycardia (n=3), idiopathic ventricular tachyca
123    A trend toward a higher incidence of left atrial tachycardia occurrence in the wide antral circumf
124 that approximately two thirds of focal right atrial tachycardias occurring in the absence of structur
125 erm procedural outcome or freedom from AF or atrial tachycardia (odds ratio [OR], 0.80; 95% confidenc
126 e, 94% of the patients remained free from AF/atrial tachycardia off antiarrhythmic drugs.
127 77 reablation group patients were free of AF/atrial tachycardia on no AADs; in contrast, in the AAD g
128 thermore, 2 of 7 ablation dogs had sustained atrial tachycardias, one of which was successfully ablat
129  atrial fibrillation (P=0.046) or paroxysmal atrial tachycardia (P<0.001) episodes.
130 y 9 (12%) of the 77 patients were free of AF/atrial tachycardia (P<0.01) throughout follow-up.
131 nd 1,420 long (>10 s) episodes of paroxysmal atrial tachycardia (PAT).
132                                         In 3 atrial tachycardia patients, PN displacement was not pos
133 ree of target arrhythmia was achieved in all atrial tachycardia patients; however, a nontargeted vent
134 on per day and 10+/-3 episodes of paroxysmal atrial tachycardia per day in group 1.
135 F termination is associated with consecutive atrial tachycardia procedures.
136 edom from atrial fibrillation/atrial flutter/atrial tachycardia recurrence was 72.5%.
137 ar follow-up, freedom from AF/atrial flutter/atrial tachycardia recurrence was significantly higher i
138 er rate of consecutive procedures because of atrial tachycardia recurrences (P = 0.003; HR, 1.71; 95%
139 ivation pattern of localized reentry (LR) in atrial tachycardia remains incompletely understood.
140  (control, n=16) and 3 canine AF-models: (1) atrial tachycardia remodeling (ATR; n=16) induced by atr
141 0.10.1+/-0.00.5+/-0.40.3+/-0.1 ATR indicates atrial tachycardia remodeling; CAF, chronic atrial fibri
142                                              Atrial tachycardia requiring RFCA deep within the CS has
143 schemes of atrial flutter and macroreentrant atrial tachycardias, reviews the technique of radiofrequ
144 = 43), 3) atrial tachycardia (n = 19) and 4) atrial tachycardia simulated by demand atrial pacing in
145 0 (28%) of 35 consecutive patients with left atrial tachycardia, the arrhythmia originated from the M
146 ntribute to the positive inotropy and sinus (atrial) tachycardia traditionally attributed to chronic,
147 es including hypertrophic cardiomyopathy and atrial tachycardia, tumor predisposition, and cognitive
148 ented with paroxysmal atrial fibrillation or atrial tachycardia underwent preablation LGE CMR.
149 ibrillation, occurrence of atrial flutter or atrial tachycardia, use of antiarrhythmic drugs, or repe
150 e highest accuracy in algorithmic mapping of atrial tachycardia/ventricular tachycardia.
151 ltiple procedures, freedom from recurrent AF/atrial tachycardia was achieved in 87%.
152                                   Incisional atrial tachycardia was excluded in the remaining patient
153                              Macro-reentrant atrial tachycardia was seen in 7 patients, and isthmus-d
154 verall, the rate of recurrent arrhythmia (AF/atrial tachycardia) was 21% at 1 year, 11% between 1 and
155                        In patients with left atrial tachycardia, we investigated whether this region
156           Paroxysmal atrial fibrillation and atrial tachycardia were invariably (100%) preceded (<5 s
157                                        Focal atrial tachycardias were ablated with point lesions that
158 nty-three consecutive patients with 27 right atrial tachycardias were included in the study.
159                      Twenty-three left-sided atrial tachycardias were mapped in 15 patients (age: 64+
160            Burst ventricular pacing excluded atrial tachycardia when the tachycardia terminated witho
161 aroxysmal atrial fibrillation and paroxysmal atrial tachycardia, which suggests that simultaneous sym
162  Five patients were documented to have focal atrial tachycardia, which was mapped to the coronary sin
163 from atrial fibrillation, atrial flutter, or atrial tachycardia while not receiving antiarrhythmic me

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top